Penman BW - Search Results

1

Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6.

Penman BW, Reece J, Smith T, Yang CS, Gelboin HV, Gonzalez FJ, Crespi CL. Penman BW, et al. Pharmacogenetics. 1993 Feb;3(1):28-39. doi: 10.1097/00008571-199302000-00003. Pharmacogenetics. 1993. PMID: 8485585

2

Human cell mutagenicity of chlorinated and unchlorinated water and the disinfection byproduct 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX).

Woodruff NW, Durant JL, Donhoffner LL, Penman BW, Crespi CL. Woodruff NW, et al. Among authors: penman bw. Mutat Res. 2001 Aug 22;495(1-2):157-68. doi: 10.1016/s1383-5718(01)00243-1. Mutat Res. 2001. PMID: 11448653

3

Mutagenicity of C24H14 PAH in human cells expressing CYP1A1.

Durant JL, Lafleur AL, Busby WF Jr, Donhoffner LL, Penman BW, Crespi CL. Durant JL, et al. Among authors: penman bw. Mutat Res. 1999 Oct 29;446(1):1-14. doi: 10.1016/s1383-5718(99)00135-7. Mutat Res. 1999. PMID: 10613181

4

A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing.

Crespi CL, Gonzalez FJ, Steimel DT, Turner TR, Gelboin HV, Penman BW, Langenbach R. Crespi CL, et al. Among authors: penman bw. Chem Res Toxicol. 1991 Sep-Oct;4(5):566-72. doi: 10.1021/tx00023a013. Chem Res Toxicol. 1991. PMID: 1793807

5

Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.

Code EL, Crespi CL, Penman BW, Gonzalez FJ, Chang TK, Waxman DJ. Code EL, et al. Among authors: penman bw. Drug Metab Dispos. 1997 Aug;25(8):985-93. Drug Metab Dispos. 1997. PMID: 9280407

6

Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450.

Crespi CL, Miller VP, Penman BW. Crespi CL, et al. Among authors: penman bw. Anal Biochem. 1997 May 15;248(1):188-90. doi: 10.1006/abio.1997.2145. Anal Biochem. 1997. PMID: 9177742 No abstract available.

7

Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus system.

Chen L, Buters JT, Hardwick JP, Tamura S, Penman BW, Gonzalez FJ, Crespi CL. Chen L, et al. Among authors: penman bw. Drug Metab Dispos. 1997 Apr;25(4):399-405. Drug Metab Dispos. 1997. PMID: 9107537

8

Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.

Crespi CL, Penman BW, Steimel DT, Smith T, Yang CS, Sutter TR. Crespi CL, et al. Among authors: penman bw. Mutagenesis. 1997 Mar;12(2):83-9. doi: 10.1093/mutage/12.2.83. Mutagenesis. 1997. PMID: 9106248

9

Development of Caco-2 cells expressing high levels of cDNA-derived cytochrome P4503A4.

Crespi CL, Penman BW, Hu M. Crespi CL, et al. Among authors: penman bw. Pharm Res. 1996 Nov;13(11):1635-41. doi: 10.1023/a:1016428304366. Pharm Res. 1996. PMID: 8956327

10

Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374.

Crespi CL, Steimel DT, Penman BW, Korzekwa KR, Fernandez-Salguero P, Buters JT, Gelboin HV, Gonzalez FJ, Idle JR, Daly AK. Crespi CL, et al. Among authors: penman bw. Pharmacogenetics. 1995 Aug;5(4):234-43. doi: 10.1097/00008571-199508000-00007. Pharmacogenetics. 1995. PMID: 8528270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results